MedTrace Logo

Mobilization With Movement Techniques of Shoulder Girdle in Patients With Chronic Adhesive Capsulitis

NCT05810766 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-09-18

No results posted yet for this study

Summary

Study will be a Randomized clinical trial to check Effects of mobilization with movement techniques of shoulder girdle on pain, range of motion and function in patients with chronic adhesive capsulitis so that we can devise a treatment protocol Total Thirty subjects will be included in this study .Out of total 15 will be randomly allocated via lottery method in group 1 and 15 will be allocated in group 2. Group 1 will receive hot packs for 15 minutes for warming up, shoulder girdle mobilization with movement techniques along with other shoulder girdle joints mobilizations (sternoclavicular, acromioclavicular, cervicothoracic and scapulothoracic joints) and conventional physical therapy treatment while group 2 will receive only hot pack for 15 minutes and conventional physical therapy management. All patients will be treated for 12 sessions, two sessions per week for 6 weeks. Shoulder pain and disability index consist of two parts, part one which assesses pain severity and part two which assesses functional disability. Study setting will be suraiya majeed trust hospital. Assessment will be done at 0 weeks, 3 weeks, and 6 weeks. Data was analysed by using SPSS version 26.

Conditions

  • Adhesive Capsulitis of Shoulder

Interventions

OTHER

mobilization with movement

MWM at glenohumeral joint and then we will add progression by adding glides at sternoclavicular and acromioclavicular joint.5 sets of painless glides of 10 repetitions will be given, with 3-minute rest between sets.

OTHER

conventional physical therapy

Hot pack for 15 minutes

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • khadija Musarat, MS* · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2023-08-05
Completion
2023-08-15

Countries

  • Pakistan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05810766 on ClinicalTrials.gov